Brad Canino Analyst Performance

Biotechnology Equity Research Analyst at Guggenheim

Brad Canino is a stock analyst at Guggenheim in the medical sector, covering 12 publicly traded companies. Over the past year, Brad Canino has issued 18 stock ratings, including buy and hold recommendations. While full access to Brad Canino's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Brad Canino's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 18 Last 0 Years
Buy Recommendations: 94.44% 17 Buy Ratings
Companies Covered: 12 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	94.4%	17 ratings
Hold	5.6%	1 ratings
Sell	0.0%	0 ratings

Out of 18 total stock ratings issued by Brad Canino at Guggenheim, the majority (94.4%) have been Buy recommendations, followed by 5.6% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	100.0% of companies on NASDAQ	12 companies

Brad Canino, an analyst at Guggenheim, currently covers 12 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 12 companies	100.0%

Brad Canino of Guggenheim specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 9 companies	75.0%
MED - DRUGS 3 companies	25.0%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
OLMA Olema Pharmaceuticals	10/8/2025	Initiated Coverage	$10.44	$20.00	Buy
CGON CG Oncology	10/7/2025	Initiated Coverage	$38.00	$90.00	Buy
CGON CG Oncology	10/7/2025	Initiated Coverage	$40.71	$90.00	Buy
CELC Celcuity	9/22/2025	Initiated Coverage	$51.88		Buy
KURA Kura Oncology	9/4/2025	Initiated Coverage	$8.43		Neutral
ORIC Oric Pharmaceuticals	9/4/2025	Initiated Coverage	$10.60	$18.00	Buy
RLAY Relay Therapeutics	9/4/2025	Initiated Coverage	$4.02	$15.00	Buy
NUVL Nuvalent	9/4/2025	Initiated Coverage	$78.82	$122.00	Buy
SMMT Summit Therapeutics	9/3/2025	Initiated Coverage	$23.52	$40.00	Buy
PYXS Pyxis Oncology	9/3/2025	Initiated Coverage	$1.47	$5.00	Buy
JANX Janux Therapeutics	9/3/2025	Initiated Coverage	$23.04	$72.00	Buy
CCCC C4 Therapeutics	9/3/2025	Initiated Coverage	$2.56	$8.00	Buy
BDTX Black Diamond Therapeutics	9/3/2025	Initiated Coverage	$2.88	$8.00	Buy
BDTX Black Diamond Therapeutics	9/3/2025	Initiated Coverage	$2.94	$8.00	Buy
JANX Janux Therapeutics	9/3/2025	Initiated Coverage	$23.98	$72.00	Buy
PYXS Pyxis Oncology	9/3/2025	Initiated Coverage	$1.91	$5.00	Buy
CCCC C4 Therapeutics	9/3/2025	Initiated Coverage	$2.71	$8.00	Buy
SMMT Summit Therapeutics	9/3/2025	Initiated Coverage	$19.44	$40.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.